Area of research
Public Health, Environmental and Occupational Health · Hematology
Research interest
Research interests include Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Glioma Diagnosis and Treatment, and Childhood Cancer Survivors' Quality of Life.
Population pharmacokinetics and dose-response relationships of mitoxantrone in children with acute myeloid leukaemia.
Integrated Germline and Somatic Molecular Profiling to Detect Cancer Predisposition Has a High Clinical Impact in Poor-Prognosis Pediatric Cancer.
Activity of STAMP inhibitors in ABL2 rearranged acute lymphoblastic leukemia is dependent on the Abl2 SH3 domain
High Expression of NTRK1 in ETV6::RUNX1 Positive Acute Lymphoblastic Leukaemia Drives Factor Independence and Sensitivity to Larotrectinib.
The 5’ fusion partner modulates response to the STAMP inhibitor asciminib in
<i>ABL</i>
-rearranged ALL
Motion of VAPB molecules reveals ER–mitochondria contact site subdomains
Precision-guided treatment in high-risk pediatric cancers.
Periodic ER-plasma membrane junctions support long-range Ca2+ signal integration in dendrites
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years
Structural dynamics of human ribosomes in situ reconstructed by exhaustive high-resolution template matching
Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies <i>LMO2/STAG2</i> Rearrangements as Extremely High Risk
Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk.
An interphase actin wave promotes mitochondrial content mixing and organelle homeostasis
PARC: a phase I/II study evaluating the safety and activity of pegylated recombinant human arginase BCT-100 in relapsed/refractory cancers of children and young adults.
Pearling Drives Mitochondrial DNA Nucleoid Distribution
Characterization of Human Engraftment and Hemophagocytic Lymphohistiocytosis in NSG-SGM3 Neonate Mice Engrafted with Purified CD34<sup>+</sup> Hematopoietic Stem Cells.
Mitochondrially-associated actin waves maintain organelle homeostasis and equitable inheritance
Providing Australian children and adolescents with equitable access to new and emerging therapies through clinical trials: a call to action.
Incidence and survival for childhood cancer by endorsed non-stage prognostic indicators in Australia.
Preventing adverse events during paediatric cancer treatment: protocol for a multi-site hybrid randomised controlled trial of catheter lock solutions (the CLOCK trial).
Author Correction: Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress
Population-level 5-year event-free survival for children with cancer in Australia.
Exploring NK cell receptor dynamics in paediatric leukaemias: implications for immunotherapy and prognosis.
Supplementary Table S2 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies <i>LMO2/STAG2</i> Rearrangements as Extremely High Risk
Supplementary Table S22 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies <i>LMO2/STAG2</i> Rearrangements as Extremely High Risk
Supplementary Figure S1 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies <i>LMO2/STAG2</i> Rearrangements as Extremely High Risk
Supplementary Figure S3 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies <i>LMO2/STAG2</i> Rearrangements as Extremely High Risk
Supplementary Figure S4 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies <i>LMO2/STAG2</i> Rearrangements as Extremely High Risk
Supplementary Table S14 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies <i>LMO2/STAG2</i> Rearrangements as Extremely High Risk
Supplementary Table S10 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies <i>LMO2/STAG2</i> Rearrangements as Extremely High Risk